Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
The Thioredoxin System: A Promising Target for Cancer Drug Development
Hiba Ghareeb
,
Norman Metanis
*
*
Corresponding author for this work
Institute of Chemistry
Research output
:
Contribution to journal
›
Review article
›
peer-review
106
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Thioredoxin System: A Promising Target for Cancer Drug Development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Promising Target
100%
Thioredoxin System
100%
Cancer Drug Development
100%
Thioredoxin
75%
Thioredoxin Reductase
75%
Cellular Homeostasis
25%
In Cancer
25%
Redox Center
25%
Intracellular Environment
25%
Cell Behavior
25%
Cancer Development
25%
Living Cells
25%
Healthy Cells
25%
Peptide-based Inhibitors
25%
Nicotinamide Adenine Dinucleotide Phosphate (NADPH)
25%
Small Molecule Targets
25%
Protein-peptide Complex
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Thioredoxin
100%
Thioredoxin Reductase
42%
Homeostasis
14%
Cancer
14%
Carboxy Terminal Sequence
14%
Cell Function
14%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
14%
Peptide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Thioredoxin
100%
Cancer Drug Development
100%
Thioredoxin Reductase
42%
Malignant Neoplasm
14%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
14%
Peptide
14%
Chemistry
Cancer Drug
100%
Thioredoxin
100%
NADPH
10%
Peptide
10%